KMLE
»çÀÌÆ® ¼Ò°³
°Ë»ö
°Ë»ö¾î Áö¿ì±â
´Ý±â
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
°í±Þ °Ë»ö ¼³Á¤
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
14
ÆäÀÌÁö:
11
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
À¯¶õŹÁ¤75mg
Ranitidine HCl 75 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
123¿ø/1 °³
´ÙÀÌÇǸ±Á¤2mg
Glimepiride 2 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
261¿ø/1 °³
´º·¾Åçĸ½¶100mg
Gabapentin 100 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
277¿ø/1 °³
´º¿Á½ÃŽÁ¤
Oxiracetam 800 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
537¿ø/1 °³
ȯÀεµ³×ÆäÁúÁ¤5mg
Donepezil HCl 5 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
993¿ø/1 °³
¾Æ·»µåÁ¤70mg
Sodium Alendronate 70 mg
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
´º·¾ÅçÁ¤800mg
Gabapentin 800 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
1092¿ø/1 °³
Á¹ÇǶ÷Á¤10mg
Zolpidem Tartrate 10 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
260¿ø/1 °³
ÅäÇǶóÆ®Á¤100mg
Topiramate 100 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
1358¿ø/1 °³
޽ºÇÉĸ½¶
Tamsulosin HCl 0.2 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
816¿ø/1 °³
¼¼·ÎÇÊĸ½¶
Acebrophylline 100 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
313¿ø/1 °³
´ÏÆç¿¡½º¾ËÁ¤30mg
Nifedipine 33 mg
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
¸ÞŸµ¥ÀÌÆ®CD¼¹æÄ¸½¶10mg
Methylphenidate HCl 10 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
621¿ø/1 °³
¸ÞŸµ¥ÀÌÆ®CD¼¹æÄ¸½¶30mg
Methylphenidate HCl 30 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
1176¿ø/1 °³
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
diacrisis
1. Áø´Ü 2. ºÐºñ¼ºÁúȯ 3. ÀÓ°è¹æÃâ
diamine oxyhydrase
µð¾Æ¹Î»ê¼Òȯ¿øÈ¿¼Ò, µð¾Æ¹Î¿Á½ÃÇÏÀ̵å¶óÁ¦
digital scan conversion
µðÁöÅнºÄµÀüȯ
digital to analog converter
µðÁöÅоƳ¯·Î±×º¯È¯±â
diphyodont
À̸¦°¡´Â, ȯġ-
disease
º´, Áúº´, Áúȯ
disillusioning process
Żȯ»ó°úÁ¤
disorder
1. Àå¾Ö 2. º´ 3. Áúȯ
displacement
1. º¯À§, ÀüÀ§ 2. ġȯ 3. ¹è±â·® 4. ¹è¼ö·®
diversion
Àüȯ(¼ú)
doctor-patient relationship
ÀÇ»çȯÀÚ°ü°è
ectopic testis
µý°÷°íȯ, À̼Ҽº°íȯ
euthenics
¿ì»ýÇÐ, ȯ°æ¿ì»ýÇÐ
exchange
±³È¯
exchange coupling
±³È¯°áÇÕ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
index case
ÃʹßȯÀÚ, ÁöÇ¥Áõ·Ê
internal conversion
³»ºÎº¯È¯
ion exchange chromatography
À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
lysogenic conversion
¿ë¿øÀüȯ
nasal cycle
ÄÚ¼øÈ¯°úÁ¤, ÄÚÁÖ±â
neurocirculatory collapse
½Å°æ¼øÈ¯ÇãÅ»
omphalomesenteric circulation
(¢¡vitelline circulation) ³È²¼øÈ¯
phage conversion
ÆÄÁöÀüȯ, ÆÄÁö±³È¯
placental circulation
ŹݼøÈ¯
portal circulation
¹®¸Æ¼øÈ¯
pulmonary ventilatory capacity
Æóȯ±â¿ë·®
radiation morbidity scoring criteria
¹æ»ç¼±ÀÌȯ°è»êÁ¡±âÁØ
scalenus neurocirculatory compression
¸ñ°¥ºñ±Ù½Å°æÇ÷°ü¾Ð¹Ú, »ç°¢±Ù½Å°æ¼øÈ¯¾Ð¹ÚÁõ
substitution compound
ġȯÈÇÕ¹°
substitution cystoplasty
ġȯ¹æ±¤¼ºÇü¼ú
ÀÌÀü
´ÙÀ½
Sponsored Links
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
aromatic ring
¹æÇâÁ·È¯(Û»úÅðéü»).
articular circumference<³ª> c. articularis
°üÀý µÑ·¹, °üÀý ȯ»ó¸é(¡ü»ßÒØü).
articulatio atlantoaxialis lateralis<³ª>
¿ÜÃø ȯÃàÃß °üÀý(èâö°ü»õîõÐμï½), ¿ÜÃø ȯÃà °üÀý(èâö°ü»õîμï½).
articulatio atlantoaxialis mediana =median atlantoaxial joint ³ª
Á¤Áß È¯ÃàÃß °üÀý, Á¤Áß(ïáñé) ȯÃà °üÀý.
articulatio atlantodentalis dorsalis<³ª>
ÈÄ È¯Ãß Ä¡µ¹ °üÀý.
articulatio atlantodentalis ventralis<³ª>
Àü ȯÃß Ä¡µ¹ °üÀý.
artificial circulation
Àΰø¼øÈ¯.
artificial testicle
Àΰø°íȯ(¡ÍÂü¯).
artificial transformation
Àΰøº¯È¯(¡Ü¨üµ).
artificial ventilation
ÀΰøÈ¯±â(¡üµÑ¨).
full ventilatory support =FVS
ÃÑȯ±âº¸Á¶
functional hallucination See hallucination
±â´ÉÀû ȯ°¢(ѦÒöîÜü³ÊÆ).
fungous disease
Áø±ÕÁúȯ, °õÆÎÀÌÆò
funiculoepididymitis
Á¤»èºÎ°íȯ¿°
galactocele
À¯·ù(À¯·ù)<<À¯¹æ(À¯¹æ)ÀÇ>>, À¯¾ç¼ö·ù(À¯¾ç¼ö·ù)<<°íȯ(°íȯ)ÀÇ>>.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
cAMP=>cyclic AMP
ȯ½ÄAMP
cAMP
ȯ½ÄAMP.
cGMP
ȯ½ÄGMP
pellet
ȯ¾à(ü¯å·).
globule
ȯ¾à, (¼Ò)±¸.
pill rolling tremor
ȯ¾àÁ¶Á¦¾çÁøÀü(ü¯å·ðàð¥ åÆòèïµ)
pill rolling tremor
ȯ¾àÁ¶Á¦¾çÁøÀü(ü¯å·ðàð¥ åÆòèïµ).
pill rolling tremor
ȯ¾àÁ¶Á¦¾çÁøÀü(ü¯å·ðàð¥åÆòèïµ)
apparition
ȯ¿µ(ü³ç±)
desoxydation =desoxidation
ȯ¿ø Å»»ê¼Ò .
reducing atmosphere
ȯ¿ø(¼º) ´ë±â.
reduction
ȯ¿ø(ü½êª), °¨¼Ò.
reducing sugar
ȯ¿ø´ç(ü½êªÓØ).
reducing substances
ȯ¿ø¹°Áú
reducible hernia =repondible h.
ȯ¿ø¼º Ç츣´Ï¾Æ(ü½êªàõ¡)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
atlantooccipital articulation
ȯÃß ÈĵΠ°üÀý(ü»õÐýÔéμï½).
atlas
ȯÃß(ü»õÐ), Á¦ÀÏ °æÃß°ñ(ð¯ìéÌòõÐÍé), µµÇØ(Óñú°), ȯÃß°ñ, ù° °æÃß°ñ.
atlas first cervical vertebra
°í¸®»À ȯÃß°ñ
atmospheric circumstances
´ë±âȯ°æ.
atrial diastole
[¼øÈ¯]½É¹æÈ®Àå±â(¡üªíåÑ¢).
atrioventricular ring
¹æ½Ç·û(Û®ãøëÌ).³»°ú,¼øÈ¯¹æ½Çȯ.
atrophia testis congenita<³ª>
¼±Ãµ¼º °íȯÀ§Ãà(Áõ).
attack rate
¹ßº´·ü, ÀÌȯÀ²
auditory hallucination
ȯû(ü³ôé)
autoallergic disease
ÀÚ°¡¾Ë·¹¸£±âÁúȯ<º´>.
autoallergic disease
ÀÚ°¡¾Ë·¹¸£±âÁúȯ<º´>.
autoimmune disease
ÀÚ°¡ ¸é¿ª Áúȯ(í»Ê«Øóæ¹òðü´)
autoimmune disease
ÀÚ°¡¸é¿ª¼ºÁúȯ(í»Ê«Øóæ¹àõòðü´)
autoimmune disease
ÀÚ°¡¸é¿ªÁúȯ<º´>.
autoimmune disease
ÀÚ°¡¸é¿ª¼ºÁúȯ
ÀÌÀü
´ÙÀ½
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
surroundings
ÁÖÀ§È¯°æ(ñ²êÌü»ÌÑ)
Tangier disease
źÁö¿¡¸£ Áúȯ(òðü´)
Tay-Sachs disease
ŸÀÌ-»è½º Áúȯ(òðü´)
transdetermination
°áÁ¤Àüȯ(̽ïÒï®üµ)
tranducer
º¯È¯±â(ܨüµÐï)
transducer cell
º¯È¯±â ¼¼Æ÷(ܨüµÐïá¬øà)
transesterification
À̽ºÅͱ³È¯(Îßüµ)
transformation
"(ÇüÁú) Àüȯ ((û¡òõ)ï®üµ), º¯Çü(ܨû¡)"
transforming principle
ÇüÁúÀüȯ¼Ò( û¡òõï®üµáÈ)
transition
"õÀÌ (ôÃì¹), ¿°±âÀüȯ (ç¤Ðñï®üµ)"
transitional mutant
¿°±â Àüȯ º¯ÀÌÁÖ(ç¤Ðñï®üµÜ¨ì¶ñ»)
transsulfuration
ȲÀüȯÀÛ¿ë(üÜï®üµíÂéÄ)
transverse mutation
¿°±âº¯È¯º¯ÀÌ(ç¤ÐñܨüµÜ¨ì¶)
transversion
¿°±âº¯È¯(ç¤Ðñܨüµ)
transversional mutant
¿°±âº¯È¯ º¯ÀÌÁÖ(ç¤ÐñܨüµÜ¨ì¶ñ»)
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
11
ÄÚµå
¿µ¹®
ÇѱÛ
B96.7
Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters
´Ù¸¥ Àå¿¡¼ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼ÀÇ Å¬·Î½ºÆ®¸®µã ÆÛÇÁ¸°Á¨½º
B96.8
Other specified bacterial agents as the cause of diseases classified to other chapters
´Ù¸¥ Àå¿¡¼ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼ÀÇ ±âŸ ¸í½ÃµÈ ¼¼±Õ¼º °¨¿°¿ø
B97
Viral agents as the cause of diseases classified to other chapters
´Ù¸¥ Àå¿¡¼ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼ÀÇ ¹ÙÀÌ·¯½º °¨¿°¿ø
B97.0
Adenovirus as the cause of diseases classified to other chapters
´Ù¸¥ Àå¿¡¼ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼ÀÇ ¾Æµ¥³ë¹ÙÀÌ·¯½º
B97.1
Enterovirus as the cause of diseases classified to other chapters
´Ù¸¥ Àå¿¡¼ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼ÀÇ ¿£Å׷ιÙÀÌ·¯½º
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
¼³¸í
fantasticans
ȯ°¢ À¯¹ß ¾à
fasciculus longitudinalis ligamenti cruciformis atlantis
ȯÃß ½ÊÀÚ Àδë Á¾¼Ó
¼öÁ÷ Á¤Áß Á¾ÁÖ ¼¶À¯·Î¼ ȯÃßÀÇ È¾Àδë¿Í ÇÔ²² ȯÃßÀÇ ½ÊÀÚ Àδ븦 Çü¼ºÇÑ´Ù. ÀÌ ¼¶À¯´Â µÎ °³ÀÇ ±ºÀ¸·Î µÇ¾î ±×Áß ÇÑ °³´Â ´ë°ø Àü¿¬À» ÇâÇÏ¿© »ó¹æÀ¸·Î, ³ª¸ÓÁö ÇÑ °³´Â ÇϹæÀÇ ÃàÃßü¿¡ ¿¬°áµÈ´Ù.
feedback
µÇ¸ÔÀ̱â, ±Íȯ, µÇ¸ÔÀÓ, Çǵå¹é
¾î¶² °úÁ¤À» Á¦¾îÇϱâ À§ÇÏ¿© Ãâ·ÂÀÇ ¾î¶² ºÎºÐÀ» ÀÔ·ÂÀ¸·Î µÇµ¹¸®´Â °Í.
ferrule
ȯ»ó±¸
first cervical vertebra
ȯÃß, Á¦ 1°æÃß
µ¿ÀǾî=atlas.
first-time dental patient
óÀ½ ³»¿øÇÑ È¯ÀÚ
fitting of crown ring
ȯ Á¢ÇÕ
flammentachygraph
¼øÈ¯ ÀÌ»ó ¹¦È±â
following chronic infectious disease
¸¸¼º °¨¿° ÁúȯÀÇ ÃßÀû
hallucination of taste
ȯ¹Ì, ¹Ì°¢Àû ȯ°¢
½ÇÁ¸ÇÏÁö ¾Ê´Â ¹Ì°¢À» ´À³¢´Â °Í,
hallucinogen
ȯ°¢Á¦, ȯ°¢ ¾à
1. ȯ°¢À» À¯¹ßÇÏ´Â ¾à¹°. 2. ²Þ, Á¤½ÅºÐ¿Áõ, ±¤½Å°ú °ü·ÃµÈ Á¤½ÅÀû º¯È¸¦ À¯¹ßÇÏ´Â ¹°Áú.
hallucinosis
ȯ°¢Áõ
ȯ°¢À» Ư¡À¸·Î ÇÏ´Â º´.
helicopod
¹Ýȯ»ó º¸ÇàÀÇ
È÷½ºÅ׸® ¹× ±âŸ Ư¼ö ȯÀÚÀÇ ÀÌ»óÇÑ °ÉÀ½°ÉÀÌ.
hemasthenosis
Ç÷¾× º¯ÁúÁõ, Ç÷¾× ¼øÈ¯ ºÎÀü
hemopathy
Ç÷¾× Áúȯ, Ç÷¾×º´
µ¿ÀǾî=hemato
ÀÌÀü
´ÙÀ½
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
10
ÆäÀÌÁö:
11
Ä«¸£ÇǾÆÄ°¼¿
A09703371
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Calcium pantothenate, Carduus Marianus extract, Cyanocobalamin, Nicotinamide, Pyridoxine HCl, Riboflavin, Thiamine HCl
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | ¹Ì»ý»ê
¶ôƾÁ¤
A09750641
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Lactobacillus acidophillus tyndalized granule
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | »èÁ¦
¼¼Æø½ÉÁÖ1g
A09702831
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Cefotaxime Sodium
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | »èÁ¦
Á¦¾Æµ¹¿¬Áúݼ¿
A09703091
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Zea mays L. extract
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | ¹Ì»ý»ê
Åä¼¼¶ôÁ¤400mg
A09750651
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Etodolac
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Ä«¸£ÇǾƿ¬Áúݼ¿
A09703031
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Calcium pantothenate, Carduus Marianus extract, Cyanocobalamin, Nicotinamide, Pyridoxine HCl, Riboflavin, Thiamine HCl
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | ¹Ì»ý»ê
¼¾½Ã´ý¿¬°í
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Centella asiatica Extract, Hydrocortisone acetate, Neomycin Sulfate
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | ¹Ì»ý»ê
¼¿ÆÅ½Å¿¬Áúݼ¿
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Ascorbic Acid, Beta-carotene 30% emulsion, Cupric oxide, Manganese sulfate, Selenium 0.1% powder, Tocopherol Acetate, Zinc Oxide
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | ¹Ì»ý»ê
Å©·Îº£°ÕÅ©¸²
A09702131
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Betamethasone dipropionate, Clotrimazole, Gentamicin Sulfate
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | »èÁ¦
Å©·Îº£°Õ¿¡ÀÌÅ©¸²
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Betamethasone valerate, Gentamicin Sulfate
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | ºñ±Þ¿©
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
parhelion
ȯÀÏ;ÇÞ¹«¸®
parheliacal
ȯÀÏÀÇ
parhelic
ȯÀÏÀÇ
parhelic
ȯÀÏÀÇ
parhelical
ȯÀÏÀÇ
apport
ȯÀÚ
practical nurse
ȯÀÚ ½ÃÁß Àü¹®ÀÇ °£È£¿ø 9
invalid chair
ȯÀÚ¿ë ¹ÙÄû ÀÇÀÚ
patient compliance
ȯÀÚÀÇ ¼ö¿ë»óÅÂ;ÀÀ³« »óÅÂ
money changer
ȯÀü»ó
agiotage
ȯÀü¾÷;ÁֽĸŸÅ
atoll
ȯÃÊ
atoll
ȯÃÊ
annelid
È¯Ãæ(Áö··ÀÌ,°Å¸Ó¸® µûÀ§)
renormalization
ȯġ°è»ê¹ý(¾çÀڷп¡ ÀÖ¾î¼ÀÇ °Ô»ê¹ýÀÇ Çϳª);renormalize
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
UNEP
United Nations Environmemt Program À¯¿£ ȯ°æ °èȹ
Ursuline
¿ì¸£¼ú¶óȸÀÇ ¼ö³à(ȯÀÚÀÇ °£È£¿Í ±³À°À» ¸ñÀûÀ¸·Î ÇÔ)
ablaut
¸ðÀ½Àüȯ(gradation)(º¸±â:sing-sang-sung)
acclaim
°¥Ã¤;ȯȣ;°¥Ã¤¸¦ º¸³»´Ù;°¥Ã¤ÇÏ´Ù
acclamation
ȯȣ;°¥Ã¤;ȯȣÅõÇ¥
acclimation
»õ ȯ°æ ¼øÀÀ;»õ dzÅä ¼øÈ
acid trip
LSD¿¡ÀÇÇÑ È¯°¢Ã¼Çè
acutecare
±Þ¼ºº´(±Þ¼º ȯÀÚ) Ä¡·áÀÇ
acyclice
ºñ¼øÈ¯½ÄÀÇ
admirer
Âù¾çÀÚ;ÆÒ;(¿©¼ºÀÇ)ȯ½ÉÀ» »ç·Á´Â ³²ÀÚ;(¿©¼º¿¡ ´ëÇÑ)¼þ¹èÀÚ;±¸È¥ÀÚ
advantaged
(Å»ý,ȯ°æµî¿¡¼)À¯¸®ÇÑ;ÇýÅùÞÀº (¾ÆÀÌ µî)
agio
ÇÁ¸®¹Ì¾ö;ȯÀü ¼ö¼ö·á;ȯÀü¾÷
agiotage
ȯÀü¾÷;ÁֽĸŸÅ
agitate
¸÷½Ã µÚÈçµé´Ù;ÈÖÁ£´Ù;µé½âÀÌ´Ù;ÈïºÐ½ÃŰ´Ù;¿©·ÐÀ» ȯ±âÇÏ´Ù;¼±µ¿ÇÏ´Ù
airless
¹Ù¶÷ÀÌ ¾ø´Â;ȯ±â°¡ ³ª»Û
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
11
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½